Literature DB >> 30601735

Revealing the Secrets of Idiopathic Pulmonary Fibrosis.

Richard K Albert1, David A Schwartz1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30601735      PMCID: PMC7050540          DOI: 10.1056/NEJMcibr1811639

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

Review 1.  Microarray analysis of idiopathic pulmonary fibrosis.

Authors:  Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2003-09       Impact factor: 6.914

2.  A nonaggregating surfactant protein C mutant is misdirected to early endosomes and disrupts phospholipid recycling.

Authors:  Michael F Beers; Arie Hawkins; Jean Ann Maguire; Adam Kotorashvili; Ming Zhao; Jennifer L Newitt; Wenge Ding; Scott Russo; Susan Guttentag; Linda Gonzales; Surafel Mulugeta
Journal:  Traffic       Date:  2011-06-28       Impact factor: 6.215

3.  Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC.

Authors:  Peter F Crossno; Vasiliy V Polosukhin; Timothy S Blackwell; Joyce E Johnson; Cheryl Markin; Paul E Moore; John A Worrell; Mildred T Stahlman; John A Phillips; James E Loyd; Joy D Cogan; William E Lawson
Journal:  Chest       Date:  2010-04       Impact factor: 9.410

4.  Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort.

Authors:  Coline H M van Moorsel; Matthijs F M van Oosterhout; Nicole P Barlo; Pim A de Jong; Joanne J van der Vis; Henk J T Ruven; H Wouter van Es; Jules M M van den Bosch; Jan C Grutters
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

5.  Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF.

Authors:  W E Lawson; S W Grant; V Ambrosini; K E Womble; E P Dawson; K B Lane; C Markin; E Renzoni; P Lympany; A Q Thomas; J Roldan; T A Scott; T S Blackwell; J A Phillips; J E Loyd; R M du Bois
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 6.  Alveolitis and collapse in the pathogenesis of pulmonary fibrosis.

Authors:  A Burkhardt
Journal:  Am Rev Respir Dis       Date:  1989-08

7.  Lung injury and fibrosis induced by a mutant form of surfactant protein C.

Authors:  Timothy S Blackwell
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

8.  Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening.

Authors:  Bridget D Stuart; Jungmin Choi; Samir Zaidi; Chao Xing; Brody Holohan; Rui Chen; Mihwa Choi; Pooja Dharwadkar; Fernando Torres; Carlos E Girod; Jonathan Weissler; John Fitzgerald; Corey Kershaw; Julia Klesney-Tait; Yolanda Mageto; Jerry W Shay; Weizhen Ji; Kaya Bilguvar; Shrikant Mane; Richard P Lifton; Christine Kim Garcia
Journal:  Nat Genet       Date:  2015-04-13       Impact factor: 41.307

9.  The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.

Authors:  Brett Ley; Chad A Newton; Isabel Arnould; Brett M Elicker; Travis S Henry; Eric Vittinghoff; Jeffrey A Golden; Kirk D Jones; Kiran Batra; Jose Torrealba; Christine Kim Garcia; Paul J Wolters
Journal:  Lancet Respir Med       Date:  2017-06-22       Impact factor: 30.700

10.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Authors:  Tasha E Fingerlin; Elissa Murphy; Weiming Zhang; Anna L Peljto; Kevin K Brown; Mark P Steele; James E Loyd; Gregory P Cosgrove; David Lynch; Steve Groshong; Harold R Collard; Paul J Wolters; Williamson Z Bradford; Karl Kossen; Scott D Seiwert; Roland M du Bois; Christine Kim Garcia; Megan S Devine; Gunnar Gudmundsson; Helgi J Isaksson; Naftali Kaminski; Yingze Zhang; Kevin F Gibson; Lisa H Lancaster; Joy D Cogan; Wendi R Mason; Toby M Maher; Philip L Molyneaux; Athol U Wells; Miriam F Moffatt; Moises Selman; Annie Pardo; Dong Soon Kim; James D Crapo; Barry J Make; Elizabeth A Regan; Dinesha S Walek; Jerry J Daniel; Yoichiro Kamatani; Diana Zelenika; Keith Smith; David McKean; Brent S Pedersen; Janet Talbert; Raven N Kidd; Cheryl R Markin; Kenneth B Beckman; Mark Lathrop; Marvin I Schwarz; David A Schwartz
Journal:  Nat Genet       Date:  2013-04-14       Impact factor: 38.330

View more
  6 in total

Review 1.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

2.  Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study.

Authors:  Won-Il Choi; Dong Yoon Lee; Hyun-Gi Choi; Choong Won Lee
Journal:  Respir Res       Date:  2019-06-10

3.  LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis.

Authors:  Xiangguang Shi; Yahui Chen; Qingmei Liu; Xueqian Mei; Jing Liu; Yulong Tang; Ruoyu Luo; Dayan Sun; Yanyun Ma; Wenyu Wu; Wenzhen Tu; Yinhuan Zhao; Weihong Xu; Yuehai Ke; Shuai Jiang; Yan Huang; Rui Zhang; Lei Wang; Yuanyuan Chen; Jingjing Xia; Weilin Pu; Honglin Zhu; Xiaoxia Zuo; Yisha Li; Jinhua Xu; Fei Gao; Dong Wei; Jingyu Chen; Wenguang Yin; Qingwen Wang; Huaping Dai; Libing Yang; Gang Guo; Jimin Cui; Nana Song; Hejian Zou; Shimin Zhao; Jörg H W Distler; Li Jin; Jiucun Wang
Journal:  Clin Transl Med       Date:  2022-01

4.  p62-Nrf2 Regulatory Loop Mediates the Anti-Pulmonary Fibrosis Effect of Bergenin.

Authors:  Qian Zeng; Tingting Zhou; Feiyan Zhao; Dayan Xiong; Bin He; Qingzhong Hua; Miao Lin; Lang Deng; Xiaoxue Sang; Weixi Xie; Jia Chen; Zun Wang; Lu Ren; Ziqiang Luo; Xiaoting Huang; Wei Liu; Siyuan Tang
Journal:  Antioxidants (Basel)       Date:  2022-02-03

5.  Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models.

Authors:  Yong Xu; Wen-Lu Hang; Xian-Mei Zhou; Qi Wu
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

6.  Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial.

Authors:  Arantza Campo; José María González-Ruiz; Enrique Andreu; Ana B Alcaide; María M Ocón; Juan De-Torres; Jesús Pueyo; Rosa Cordovilla; Eva Villaron; Fermín Sanchez-Guijo; Miguel Barrueco; Jorge Nuñez-Córdoba; Felipe Prósper; Javier J Zulueta
Journal:  ERJ Open Res       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.